By Science Daily 03/23/2018
“…Results of a recent NRG Oncology study, NRG Oncology/RTOG 0126, show that high-dose radiotherapy did not improve survival for men with intermediate-risk prostate cancer but did improve biochemical control and rates of distant metastases, when compared to standard radiotherapy. …”
Read the entire article: https://www.sciencedaily.com/releases/2018/03/180323121752.htm
